摘要
目的:观察葶苈大枣泻肺汤合导痰汤(以下简称"中药肺癌方")联合化疗治疗痰瘀阻肺型肺癌临床效果。方法:选择我院40例痰瘀阻肺型肺癌患者作为观察对象,随机分为治疗组(20例)和对照组(20例),两组患者均进行化疗治疗,在此基础上给予治疗组患者中药肺癌方,3个月后比较疗效。结果:治疗组、对照组近期总有效率分别为90.0%和65.0%,P<0.05;治疗组患者生活质量提高率为85.0%,明显高于对照组(45.0%),P<0.05。结论:中药肺癌方联合化疗治疗痰瘀阻肺型肺癌具有安全性和有效性,能够迅速改善患者临床症状,提升机体免疫力和生活质量。
Objective： To observe the clinical efficacy of Tingli Dazao Xiefei Decoction and Daotan Decoction combined withchemotherapy on lung cancer in retention of phlegm and blood stasis type. Methods： 40 patients with phlegm and blood stasis resistancetype lung cancer were selected as research objects in our hospital and randomly divided into a treatment group （20 cases） and a controlgroup （20 cases）. Patients in the two groups were treated with chemotherapy, while patients in the treatment group given Chinese medicineprescription for lung cancer, 3 months later, the efficacy was compared. Results： The total effective rates of the treatment group and thecontrol group were respectively 90.0% and 65.0% ,P〈0.05; Life quality improvement rate of the treatment group was 85.0%, significantlyhigher than that of the control group （45.0%）, P〈0.05; Conclusion： Traditional Chinese Medicine prescriptions for lung cancer combinedwith chemotherapy has the safety and effect on lung cancer in retention of phlegm and blood stasis type, which can rapidly improve theclinical symptoms and enhance immunity and life quality.
出处
《中医临床研究》
2014年第30期131-132,共2页
Clinical Journal Of Chinese Medicine
关键词
葶苈大枣泻肺汤
导痰汤
痰瘀阻肺型肺癌
Tingli Dazao Xiefei Decoction
Daotan Decoction
Retention of phlegm and blood stasis type
